Yüklüyor......
Neoadjuvant strategies for pancreatic cancer
Pancreatic cancer (PC) is the fourth cause of cancer death in Western countries, the only chance for long term survival is an R0 surgical resection that is feasible in about 10%-20% of all cases. Five years cumulative survival is less than 5% and rises to 25% for radically resected patients. About 4...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4110569/ https://ncbi.nlm.nih.gov/pubmed/25071332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i28.9374 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|